ClinConnect ClinConnect Logo
Search / Trial NCT03152721

The Effect of Parkinson Kinetigraph Recordings on the Management and Outcome in Parkinson's Disease

Launched by SAHLGRENSKA UNIVERSITY HOSPITAL · May 12, 2017

Trial Information

Current as of August 11, 2025

Completed

Keywords

Accelerometry Home Based Motor Complications Parkinson Kineti Graph Registry

ClinConnect Summary

Patients that have previously not performed a PKG recording will be recruited from the WestPORTS community based cohort of outpatients with PD in West Sweden. The WestPORTS study includes self-assessments like PDQ8 and NMS-Q as well as PKG recordings. On inclusion in WestPORTS-Int subjects will be randomized by minimization for age, gender and disease duration into one of two study arms. In the intervention group the PKG recording of the subject will be made available, together with a summarized interpretation, to the subject's regular neurologist/geriatrician before the next scheduled visi...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Clinical diagnosis of Parkinson's disease (ICD G209) according to medical records
  • 2. A visit to an outpatient neurological or geriatric clinic in the region Vastra Gotaland, Sweden within the last -1 to -7 months according to medical records.
  • 3. Randomized to invitation to participate in the WestPORTS objective measurement Cohort study (NCT03130595) by 1:4 randomization based on the full population fulfilling criteria 1 and 2.
  • 4. Written informed consent
  • 5. No previous PKG recording has been performed with the subject.
  • Exclusion Criteria:
  • 1. Withdrawal of consent.
  • 2. Unable to wear a PKG on either wrist.
  • 3. The patient's physician is the PI of the study (F Bergquist)

About Sahlgrenska University Hospital

Sahlgrenska University Hospital, a leading healthcare institution in Sweden, is at the forefront of clinical research and innovation. Affiliated with the University of Gothenburg, the hospital integrates advanced medical care with cutting-edge research, facilitating a collaborative environment for scientific exploration and clinical trials. With a commitment to improving patient outcomes, Sahlgrenska University Hospital focuses on a wide range of therapeutic areas, leveraging its multidisciplinary expertise to advance healthcare solutions. The institution is dedicated to fostering ethical research practices and ensuring the highest standards of patient safety and care in all clinical trials.

Locations

Göteborg, , Sweden

Patients applied

0 patients applied

Trial Officials

Filip Bergquist

Principal Investigator

Göteborg University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials